Healthcare

Nogra Pharma announces out-licensing agreement with Torii Pharmaceutical for Japan for New Chemical Entity topical acne treatment

January 26, 2023 Staff

Nogra Pharma announces out-licensing agreement with Torii Pharmaceutical for Japan for New Chemical Entity topical acne treatment NAC-GED-0507 is a...

Cell BioEngines Enters into an Exclusive Worldwide Agreement to Develop and Commercialize Potent Immune Cell States to Cure Cancer

January 26, 2023 Staff

Mount Sinai’s Dr. Nina Bhardwaj and Cell BioEngines Founder and CEO Dr. Ajay Vishwakarma Mount Sinai’s Dr. Nina Bhardwaj and...

Press Release: NEJM publishes once-weekly efanesoctocog alfa Phase 3 data demonstrating its potential to transform the treatment landscape for people with hemophilia A

January 26, 2023 Staff

NEJM publishes once-weekly efanesoctocog alfa Phase 3 data demonstrating its potential to transform the treatment landscape for people with hemophilia...

STERIS to Host a Conference Call for Fiscal 2023 Third Quarter Financial Results on February 9, 2023

January 26, 2023 Staff

DUBLIN, IRELAND, Jan. 25, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it...

180 Life Sciences Announces Publication of a Review on the Treatments for Early Stage Dupuytren’s Disease

January 25, 2023 Staff

PALO ALTO, Calif., Jan. 25, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the...

Newsight Imaging to Present at Drive TLV Smart Mobility Events in Silicon Valley and Atlanta

January 25, 2023 Staff

NESS ZIONA, Israel, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Newsight Imaging Ltd. (“Newsight”), a leading semiconductor innovator developing proprietary 3D...

Vir Biotechnology Announces Retirement of CEO George Scangos, Ph.D.; Appoints Marianne De Backer, MSc, Ph.D., MBA, as Successor

January 25, 2023 Staff

– Dr. De Backer to assume CEO role on April 3, 2023 – – Upon his retirement as CEO, Dr....

Catalyst Pharmaceuticals Completes the Acquisition of U.S. Rights to FYCOMPA® (Perampanel) CIII

January 25, 2023 Staff

Strengthens its Commercial Portfolio with the First and Only AMPA Receptor Antagonist Marketed Product for Epilepsy Bolsters Presence in Neuroscience...

Dante Genomics’ sequencing hub in Dubai receives ISO 15189 Medical Laboratory accreditation to bring clinical whole genome sequencing to the next billion patients

January 25, 2023 Staff

NEW YORK, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Dante Genomics, a global leader in genomics and precision medicine, announced today...

Small Pharma Reports Fiscal Third Quarter 2023 Highlights

January 25, 2023 Staff

Positive top-line results from Phase IIa trial of SPL026 in Major Depressive Disorder New SPL026 trials underway and screening commenced...

Cidara Therapeutics and Melinta Therapeutics Announce FDA Advisory Committee Recommends Approval of Rezafungin for the Treatment of Candidemia and Invasive Candidiasis

January 25, 2023 Staff

FDA decision expected by PDUFA target action date of March 22, 2023 If approved, rezafungin will be the first new...

Small Pharma Reports Positive Top-line Results from Phase IIa Trial of SPL026 in Major Depressive Disorder

January 25, 2023 Staff

First placebo-controlled efficacy study completed to date exploring a short-duration psychedelic for depression demonstrates rapid and durable response Primary endpoint...

VPM oversees clinical trial and translational project management – Positive Phase I data of client Memo Therapeutics AG

January 25, 2023 Staff

HANNOVER, Germany, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Vakzine Projekt Management GmbH (VPM), a German drug development consultancy and service...

InnovAge to Announce Fiscal Second Quarter 2023 Financial Results and Host Conference Call Tuesday, February 7, 2023

January 25, 2023 Staff

DENVER, Jan. 24, 2023 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV) will release its 2023 fiscal second quarter...

Qualigen Therapeutics Initiates Good Laboratory Practice (GLP) Toxicology Studies on QN-302

January 24, 2023 Staff

CARLSBAD, Calif., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,” Nasdaq: QLGN), a diversified life...

For the 14th Year, Inovalon Provides Charitable Support to Local, National, And International Organizations

January 24, 2023 Staff

Long-standing, Employee-driven Support of Philanthropic Efforts Grows 20% Year-Over-YearBOWIE, Md., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Inovalon, a leading provider...

Hydreight Technologies Inc Begins Trading on the Frankfurt Stock Exchange

January 24, 2023 Staff

VANCOUVER, British Columbia and LAS VEGAS, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. ("Hydreight" or the "Company") (TSXV:...

BioCorRx Appoints Pharmaceutical & Finance Veteran Harsha Murthy to the Board of Directors

January 24, 2023 Staff

ANAHEIM, CA, Jan. 24, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative...

Nexalin Technology Appoints Medical Device Veteran Michael Nketiah as Senior Vice President of Quality, Clinical and Regulatory

January 24, 2023 Staff

HOUSTON, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW), today announced the...

eGenesis Announces Knut Niss as Chief Technology Officer

January 24, 2023 Staff

CAMBRIDGE, Mass., Jan. 24, 2023 (GLOBE NEWSWIRE) -- eGenesis, a biotechnology company developing human-compatible organs and cells for the treatment...

Healthcare

Nogra Pharma announces out-licensing agreement with Torii Pharmaceutical for Japan for New Chemical Entity topical acne treatment

Cell BioEngines Enters into an Exclusive Worldwide Agreement to Develop and Commercialize Potent Immune Cell States to Cure Cancer

Press Release: NEJM publishes once-weekly efanesoctocog alfa Phase 3 data demonstrating its potential to transform the treatment landscape for people with hemophilia A

STERIS to Host a Conference Call for Fiscal 2023 Third Quarter Financial Results on February 9, 2023

180 Life Sciences Announces Publication of a Review on the Treatments for Early Stage Dupuytren’s Disease

Newsight Imaging to Present at Drive TLV Smart Mobility Events in Silicon Valley and Atlanta

Vir Biotechnology Announces Retirement of CEO George Scangos, Ph.D.; Appoints Marianne De Backer, MSc, Ph.D., MBA, as Successor

Catalyst Pharmaceuticals Completes the Acquisition of U.S. Rights to FYCOMPA® (Perampanel) CIII

Dante Genomics’ sequencing hub in Dubai receives ISO 15189 Medical Laboratory accreditation to bring clinical whole genome sequencing to the next billion patients

Small Pharma Reports Fiscal Third Quarter 2023 Highlights

Cidara Therapeutics and Melinta Therapeutics Announce FDA Advisory Committee Recommends Approval of Rezafungin for the Treatment of Candidemia and Invasive Candidiasis

Small Pharma Reports Positive Top-line Results from Phase IIa Trial of SPL026 in Major Depressive Disorder

VPM oversees clinical trial and translational project management – Positive Phase I data of client Memo Therapeutics AG

InnovAge to Announce Fiscal Second Quarter 2023 Financial Results and Host Conference Call Tuesday, February 7, 2023

Qualigen Therapeutics Initiates Good Laboratory Practice (GLP) Toxicology Studies on QN-302

For the 14th Year, Inovalon Provides Charitable Support to Local, National, And International Organizations

Hydreight Technologies Inc Begins Trading on the Frankfurt Stock Exchange

BioCorRx Appoints Pharmaceutical & Finance Veteran Harsha Murthy to the Board of Directors

Nexalin Technology Appoints Medical Device Veteran Michael Nketiah as Senior Vice President of Quality, Clinical and Regulatory

eGenesis Announces Knut Niss as Chief Technology Officer

Erickson Senior Living Standardizes and Modernizes Physical Security Across its Enterprise with Genetec Security Center

Frontera Therapeutics Doses First Patient in a Clinical Trial of FT-003 Gene Therapy for the Treatment of Wet AMD

Inovalon Adds All-payer Claims Management Software to the PointClickCare Marketplace, Expanding Partnership

Artelo Biosciences Completes Enrollment of the Phase 1b Stage of its CAReS Clinical Trial Evaluating ART27.13 for the Treatment of Cancer-Related Anorexia and Weight Loss

Y-mAbs and the European Medicines Agency Reach Agreement on the Pediatric Investigation Plan for Naxitamab

You may have missed